Seidman A - Search Results

1

A randomized phase 2 trial comparing 3-hour versus 96-hour infusion schedules of paclitaxel for the treatment of metastatic breast cancer.

Moulder SL, Holmes FA, Tolcher AW, Thall P, Broglio K, Valero V, Buzdar AU, Arbuck SG, Seidman A, Hortobagyi GN. Moulder SL, et al. Among authors: seidman a. Cancer. 2010 Feb 15;116(4):814-21. doi: 10.1002/cncr.24870. Cancer. 2010. PMID: 20052721 Free PMC article. Clinical Trial.

2

Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumors.

Seidman AD, Scher HI, Heinemann MH, Bajorin DF, Sternberg CN, Dershaw DD, Silverberg M, Bosl GJ. Seidman AD, et al. Cancer. 1991 Dec 15;68(12):2561-5. doi: 10.1002/1097-0142(19911215)68:12<2561::aid-cncr2820681205>3.0.co;2-g. Cancer. 1991. PMID: 1933802 Clinical Trial.

3

Taxol plus recombinant human granulocyte-colony stimulating factor as initial and as salvage chemotherapy for metastatic breast cancer: a preliminary report.

Seidman AD, Reichman BS, Crown JP, Yao TJ, Heelan R, Hakes TB, Lebwohl DE, Gilewski TA, Surbone A, Currie V, et al. Seidman AD, et al. J Natl Cancer Inst Monogr. 1993;(15):171-5. J Natl Cancer Inst Monogr. 1993. PMID: 7517153

4

Quality of life in phase II trials: a study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel plus granulocyte colony-stimulating factor.

Seidman AD, Portenoy R, Yao TJ, Lepore J, Mont EK, Kortmansky J, Onetto N, Ren L, Grechko J, Beltangady M, et al. Seidman AD, et al. J Natl Cancer Inst. 1995 Sep 6;87(17):1316-22. doi: 10.1093/jnci/87.17.1316. J Natl Cancer Inst. 1995. PMID: 7544834

5

Phase II trial of paclitaxel by 3-hour infusion as initial and salvage chemotherapy for metastatic breast cancer.

Seidman AD, Tiersten A, Hudis C, Gollub M, Barrett S, Yao TJ, Lepore J, Gilewski T, Currie V, Crown J, et al. Seidman AD, et al. J Clin Oncol. 1995 Oct;13(10):2575-81. doi: 10.1200/JCO.1995.13.10.2575. J Clin Oncol. 1995. PMID: 7595709 Clinical Trial.

6

Phase II trial of carboplatin and etoposide in metastatic breast cancer.

Crown J, Hakes T, Reichman B, Lebwohl D, Gilewski T, Surbone A, Currie V, Yao TJ, Hudis C, Seidman A, et al. Crown J, et al. Among authors: seidman a. Cancer. 1993 Feb 15;71(4):1254-7. doi: 10.1002/1097-0142(19930215)71:4<1254::aid-cncr2820710414>3.0.co;2-x. Cancer. 1993. PMID: 8435802 Clinical Trial.

7

Central nervous system progression of metastatic breast cancer in patients treated with paclitaxel.

Freilich RJ, Seidman AD, DeAngelis LM. Freilich RJ, et al. Among authors: seidman ad. Cancer. 1995 Jul 15;76(2):232-6. doi: 10.1002/1097-0142(19950715)76:2<232::aid-cncr2820760212>3.0.co;2-0. Cancer. 1995. PMID: 8625097 Clinical Trial.

8

Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: a phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancer.

Seidman AD, Hochhauser D, Gollub M, Edelman B, Yao TJ, Hudis CA, Francis P, Fennelly D, Gilewski TA, Moynahan ME, Currie V, Baselga J, Tong W, O'Donaghue M, Salvaggio R, Auguste L, Spriggs D, Norton L. Seidman AD, et al. J Clin Oncol. 1996 Jun;14(6):1877-84. doi: 10.1200/JCO.1996.14.6.1877. J Clin Oncol. 1996. PMID: 8656256 Clinical Trial.

9

Paclitaxel: the long and short of it.

Seidman AD. Seidman AD. Cancer J Sci Am. 1995 Nov-Dec;1(4):250-1. Cancer J Sci Am. 1995. PMID: 9166484 No abstract available.

10

Docetaxel and paclitaxel in breast cancer therapy: present status and future prospects.

D'Andrea GM, Seidman AD. D'Andrea GM, et al. Among authors: seidman ad. Semin Oncol. 1997 Aug;24(4 Suppl 13):S13-27-S13-44. Semin Oncol. 1997. PMID: 9335514 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

221 results

Search Page

Filters